semi-mechanistic pk/pd model effect odanacatib, a cathespin k inhibtor, on bone turnover
Published 3 years ago • 141 plays • Length 14:18Download video MP4
Download video MP3
Similar videos
-
1:16
membraneplus v2 - mechanistic permeability/hepatocyte models
-
5:13
simulations plus - company overview
-
1:49:42
applying mechanistic modeling to predict food effects on drugs: approaches & special considerations
-
1:11
simulations plus 2021
-
26:26
using a pop pk/pd model developed on phase i to select dose for phase ii an example with an igg1 mab
-
58:18
unlocking the power of pbpk modeling: pbpk for first-in-human and beyond
-
57:55
pedro mendes, multiscale hybrid differential equation and agent-based models
-
1:03:02
pbpk modeling for identifying and mitigating absorption risks in early drug development
-
3:01
about us
-
14:09
population pharmacokinetic evaluation & missed-dose simulations eslicarbazepine acetate monotherapy
-
0:58
pkplus 2 noncompartmental (nca) & compartmental pk modeling
-
28:57
pre clinical track: ophthalmic clinical pharmacokinetic/pharmacodynamic prediction using pbpk model
-
1:44
clinical pharmacology modeling and simulation (cpms)
-
1:51
drug design...meet pbpk with the aidd™ module
-
1:52
pbpk modeling supports approval of breakthrough cancer drug
-
54:26
early assessment of pk properties using admet predictor® htpk simulation technology
-
1:28
scientific reports : equilibrated atomic models of outward-facing p-glycoprotein and effect...
-
1:20:40
mechanistic in vitro dissolution pbpk models to drive drug development
-
1:09
patient education for clinical research
-
1:31
gastroplus® 9.9